Stay updated on Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial page.

Latest updates to the Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe ClinicalTrials.gov page now displays the study record for the temozolomide and nivolumab colorectal cancer trial, including its design, eligibility criteria, and record details, instead of a 403 error.SummaryDifference46%

- Check14 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site as revision v3.8.0 instead of v3.7.2. The study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA banner announces that NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” in response to an executive order, with links to updates and FAQs.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2; the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the usual study details, indicating the record is temporarily inaccessible or restricted.SummaryDifference18%

Stay in the know with updates to Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Temozolomide Plus Nivolumab in Colorectal Cancer Clinical Trial page.